CASE REPORT
The pregnancy journey of a patient with end-stage renal disease on hemodialysis: A case study
More details
Hide details
1
Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, MALAYSIA
2
Klinik Kesihatan Meranti, Pasir Mas, Kelantan, MALAYSIA
Publication date: 2024-03-14
Electron J Gen Med 2024;21(2):em575
KEYWORDS
ABSTRACT
Pregnancy in patients with end-stage renal disease (ESRD) is considered a very high-risk and is not recommended
as it might cause fatal consequences for both the mother and the fetus. Even though chronic kidney disease affects
the physiological components of fertility, decreasing the possibility of spontaneous conceptions, unwanted
pregnancies still happen, and a small percentage of women with ESRD become pregnant. All women with kidney
disease should have access to specialists in renal disease and pregnancy who can support, care for, and monitor
them during their pregnancy. We reported a case of a 37-year-old primigravida who has ESRD on hemodialysis.
The pregnancy journey was uneasy, but eventually she successfully passed through it. The most challenging issues
to treat and manage throughout this pregnancy are anemia, the risks of eclampsia, and uncontrolled
hypertension. The management of this patient requires multidisciplinary and shared care monitoring by the
nephrologist, obstetrician, and primary care doctor.
REFERENCES (12)
1.
Manisco G, Potì M, Maggiulli G, Di Tullio M, Losappio V, Vernaglione L. Pregnancy in end-stage renal disease patients on dialysis: How to achieve a successful delivery. Clin Kidney J. 2015;8(3):293-9.
https://doi.org/10.1093/ckj/sf... PMid:26034591 PMCid:PMC4440463.
3.
Nadeau-Fredette AC, Hladunewich M, Hui D, Keunen J, Chan CT. End-stage renal disease and pregnancy. Adv Chronic Kidney Dis. 2013;20(3):246-52.
https://doi.org/10.1053/j.ackd... PMid:23928389.
4.
Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019;20(1):401.
https://doi.org/10.1186/s12882... PMid:31672135 PMCid:PMC6822421.
6.
Wei Q, Zhang L, Duan M-F, Wang Y-M, Huang N, Song C-R. Use of angiotensin II receptor blocker during pregnancy: A case report. Medicine (Baltimore). 2021;100(3):e24304.
https://doi.org/10.1097/MD.000... PMid:33546057 PMCid:PMC7837885.
7.
Asamiya Y, Otsubo S, Matsuda Y, et al. The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int. 2009;75(11):1217-22.
https://doi.org/10.1038/ki.200... PMid:19242506.
9.
Son R, Fujimaru T, Kimura T, et al. Association between serum ferritin levels and clinical outcomes in maintenance hemodialysis patients: A retrospective single-center cohort study. Ren Replace Ther. 2019;5:17.
https://doi.org/10.1186/s41100....
10.
Tanhehco YC, Berns JS. Red blood cell transfusion risks in patients with end-stage renal disease. Semin Dial. 2012;25(5):539-44.
https://doi.org/10.1111/j.1525... PMid:22686519 PMCid:PMC3676886.
11.
Mikhail A, Brown C, Williams JA, et al. Clinical practice guideline anemia of chronic kidney disease. BMC Nephrol. 2017;18(1):345.
https://doi.org/10.1186/s12882... PMid:29191165 PMCid:PMC5709852.
12.
Shah R, Haddad N, Vachharajani TJ, Asif A, Agarwal A. Thrombocytopenia in ESRD patients: Epidemiology, mechanisms and interventional nephrology perspective. Semin Dial. 2014;27(6):618-25.
https://doi.org/10.1111/sdi.12... PMid:24612107.